Report Summary
The global Animal-derived Immune Globulin Products market is valued at million US$ in 2020 and will reach million US$ by the end of 2027, growing at a CAGR of during 2021-2027. The objectives of this study are to define, segment, and project the size of the Animal-derived Immune Globulin Products market based on company, product type, end user and key regions.
This report studies the global market size of Animal-derived Immune Globulin Products in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Animal-derived Immune Globulin Products in these regions.
This research report categorizes the global Animal-derived Immune Globulin Products market by top players/brands, region, type and end user. This report also studies the global Animal-derived Immune Globulin Products market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Pfizer
Rare Disease Therapeutics
Instituto Bioclon
Merck & Co
Sanofi
Protherics
Genzyme Corporation
Market size by Product
IVIg Liquid
IVIg Powder
Market size by End User
Immunodeficiency
Autoimmune Disease
Acute Infection
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Animal-derived Immune Globulin Products market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2020, and forecast to 2027.
To understand the structure of Animal-derived Immune Globulin Products market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Animal-derived Immune Globulin Products companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Animal-derived Immune Globulin Products submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Animal-derived Immune Globulin Products are as follows:
History Year: 2017-2020
Base Year: 2020
Estimated Year: 2020
Forecast Year 2021 to 2027
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Animal-derived Immune Globulin Products market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table Of Contents
Table of Contents
1 Study Coverage
1.1 Animal-derived Immune Globulin Products Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Animal-derived Immune Globulin Products Market Size Growth Rate by Product
1.4.2 IVIg Liquid
1.4.3 IVIg Powder
1.5 Market by End User
1.5.1 Global Animal-derived Immune Globulin Products Market Size Growth Rate by End User
1.5.2 Immunodeficiency
1.5.3 Autoimmune Disease
1.5.4 Acute Infection
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Animal-derived Immune Globulin Products Market Size
2.1.1 Global Animal-derived Immune Globulin Products Revenue 2017-2027
2.1.2 Global Animal-derived Immune Globulin Products Sales 2017-2027
2.2 Animal-derived Immune Globulin Products Growth Rate by Regions
2.2.1 Global Animal-derived Immune Globulin Products Sales by Regions
2.2.2 Global Animal-derived Immune Globulin Products Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Animal-derived Immune Globulin Products Sales by Manufacturers
3.1.1 Animal-derived Immune Globulin Products Sales by Manufacturers
3.1.2 Animal-derived Immune Globulin Products Sales Market Share by Manufacturers
3.1.3 Global Animal-derived Immune Globulin Products Market Concentration Ratio (CR5 and HHI)
3.2 Animal-derived Immune Globulin Products Revenue by Manufacturers
3.2.1 Animal-derived Immune Globulin Products Revenue by Manufacturers (2017-2020)
3.2.2 Animal-derived Immune Globulin Products Revenue Share by Manufacturers (2017-2020)
3.3 Animal-derived Immune Globulin Products Price by Manufacturers
3.4 Animal-derived Immune Globulin Products Manufacturing Base Distribution, Product Types
3.4.1 Animal-derived Immune Globulin Products Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Animal-derived Immune Globulin Products Product Type
3.4.3 Date of International Manufacturers Enter into Animal-derived Immune Globulin Products Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Animal-derived Immune Globulin Products Sales by Product
4.2 Global Animal-derived Immune Globulin Products Revenue by Product
4.3 Animal-derived Immune Globulin Products Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Animal-derived Immune Globulin Products Breakdown Data by End User
6 North America
6.1 North America Animal-derived Immune Globulin Products by Countries
6.1.1 North America Animal-derived Immune Globulin Products Sales by Countries
6.1.2 North America Animal-derived Immune Globulin Products Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Animal-derived Immune Globulin Products by Product
6.3 North America Animal-derived Immune Globulin Products by End User
7 Europe
7.1 Europe Animal-derived Immune Globulin Products by Countries
7.1.1 Europe Animal-derived Immune Globulin Products Sales by Countries
7.1.2 Europe Animal-derived Immune Globulin Products Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Animal-derived Immune Globulin Products by Product
7.3 Europe Animal-derived Immune Globulin Products by End User
8 Asia Pacific
8.1 Asia Pacific Animal-derived Immune Globulin Products by Countries
8.1.1 Asia Pacific Animal-derived Immune Globulin Products Sales by Countries
8.1.2 Asia Pacific Animal-derived Immune Globulin Products Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Animal-derived Immune Globulin Products by Product
8.3 Asia Pacific Animal-derived Immune Globulin Products by End User
9 Central & South America
9.1 Central & South America Animal-derived Immune Globulin Products by Countries
9.1.1 Central & South America Animal-derived Immune Globulin Products Sales by Countries
9.1.2 Central & South America Animal-derived Immune Globulin Products Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Animal-derived Immune Globulin Products by Product
9.3 Central & South America Animal-derived Immune Globulin Products by End User
10 Middle East and Africa
10.1 Middle East and Africa Animal-derived Immune Globulin Products by Countries
10.1.1 Middle East and Africa Animal-derived Immune Globulin Products Sales by Countries
10.1.2 Middle East and Africa Animal-derived Immune Globulin Products Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Animal-derived Immune Globulin Products by Product
10.3 Middle East and Africa Animal-derived Immune Globulin Products by End User
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Company Business Overview
11.1.3 Pfizer Animal-derived Immune Globulin Products Sales, Revenue and Gross Margin (2017-2020)
11.1.4 Pfizer Animal-derived Immune Globulin Products Products Offered
11.1.5 Pfizer Recent Development
11.2 Rare Disease Therapeutics
11.2.1 Rare Disease Therapeutics Company Details
11.2.2 Company Business Overview
11.2.3 Rare Disease Therapeutics Animal-derived Immune Globulin Products Sales, Revenue and Gross Margin (2017-2020)
11.2.4 Rare Disease Therapeutics Animal-derived Immune Globulin Products Products Offered
11.2.5 Rare Disease Therapeutics Recent Development
11.3 Instituto Bioclon
11.3.1 Instituto Bioclon Company Details
11.3.2 Company Business Overview
11.3.3 Instituto Bioclon Animal-derived Immune Globulin Products Sales, Revenue and Gross Margin (2017-2020)
11.3.4 Instituto Bioclon Animal-derived Immune Globulin Products Products Offered
11.3.5 Instituto Bioclon Recent Development
11.4 Merck & Co
11.4.1 Merck & Co Company Details
11.4.2 Company Business Overview
11.4.3 Merck & Co Animal-derived Immune Globulin Products Sales, Revenue and Gross Margin (2017-2020)
11.4.4 Merck & Co Animal-derived Immune Globulin Products Products Offered
11.4.5 Merck & Co Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Company Business Overview
11.5.3 Sanofi Animal-derived Immune Globulin Products Sales, Revenue and Gross Margin (2017-2020)
11.5.4 Sanofi Animal-derived Immune Globulin Products Products Offered
11.5.5 Sanofi Recent Development
11.6 Protherics
11.6.1 Protherics Company Details
11.6.2 Company Business Overview
11.6.3 Protherics Animal-derived Immune Globulin Products Sales, Revenue and Gross Margin (2017-2020)
11.6.4 Protherics Animal-derived Immune Globulin Products Products Offered
11.6.5 Protherics Recent Development
11.7 Genzyme Corporation
11.7.1 Genzyme Corporation Company Details
11.7.2 Company Business Overview
11.7.3 Genzyme Corporation Animal-derived Immune Globulin Products Sales, Revenue and Gross Margin (2017-2020)
11.7.4 Genzyme Corporation Animal-derived Immune Globulin Products Products Offered
11.7.5 Genzyme Corporation Recent Development
12 Future Forecast
12.1 Animal-derived Immune Globulin Products Market Forecast by Regions
12.1.1 Global Animal-derived Immune Globulin Products Sales Forecast by Regions 2021-2027
12.1.2 Global Animal-derived Immune Globulin Products Revenue Forecast by Regions 2021-2027
12.2 Animal-derived Immune Globulin Products Market Forecast by Product
12.2.1 Global Animal-derived Immune Globulin Products Sales Forecast by Product 2021-2027
12.2.2 Global Animal-derived Immune Globulin Products Revenue Forecast by Product 2021-2027
12.3 Animal-derived Immune Globulin Products Market Forecast by End User
12.4 North America Animal-derived Immune Globulin Products Forecast
12.5 Europe Animal-derived Immune Globulin Products Forecast
12.6 Asia Pacific Animal-derived Immune Globulin Products Forecast
12.7 Central & South America Animal-derived Immune Globulin Products Forecast
12.8 Middle East and Africa Animal-derived Immune Globulin Products Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Animal-derived Immune Globulin Products Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
